Abstract
Aspergillus funiculosus NCIM 1029 has been reported for the production of kojic acid exhibiting antibacterial, antifungal and larvicidal activity against 3rd instar larvae of Aedes aegypti.
Aim of the Study: To check the antifeedant, acute toxicity and sublethal growth effects of fungal metabolite, kojic acid against the agriculture pest, Spodoptera litura.
Materials and Methods: Kojic acid was checked for feeding deterrence activity against 4th instar larvae of S. litura in comparison to insect antifeedant, azadirachtin. Reduction in the weight and length of the larvae was evaluated after three days of exposure to kojic acid (400μg/ml). The effect of kojic acid on pupation and adult emergence was also studied.
Results: On determination of feeding deterrence, the DC50 value for kojic acid was found to be 180.645 ± 6.35μg/ml on comparison to azadirachtin (DC50 = 41.372 ± 2.21). The LD50 & LD90 values of kojic acid were found to be 693.52± 51.31 and 1889.13 ± 279.03μg/ml, respectively. The reduction in larval weight and length were 83.24 and 87.50%, respectively. The percentage pupation and adult emergence were reduced by 69% and 64% for the exposed larvae.
Conclusions: Kojic acid showed moderate feeding deterrence, acute toxicity and sublethal growth effects against S. litura.
Keywords: Aspergillus funiculosus, kojic acid, Spodoptera litura, acute toxicity, antifeedant.
The Natural Products Journal
Title:Feeding Deterrence, Acute Toxicity and Sublethal Growth Effects of Kojic Acid Isolated from Aspergillus funiculosus
Volume: 4 Issue: 1
Author(s): Siddhardha Busi, Jobina Rajkumari and Sairengpuii Hnamte
Affiliation:
Keywords: Aspergillus funiculosus, kojic acid, Spodoptera litura, acute toxicity, antifeedant.
Abstract: Aspergillus funiculosus NCIM 1029 has been reported for the production of kojic acid exhibiting antibacterial, antifungal and larvicidal activity against 3rd instar larvae of Aedes aegypti.
Aim of the Study: To check the antifeedant, acute toxicity and sublethal growth effects of fungal metabolite, kojic acid against the agriculture pest, Spodoptera litura.
Materials and Methods: Kojic acid was checked for feeding deterrence activity against 4th instar larvae of S. litura in comparison to insect antifeedant, azadirachtin. Reduction in the weight and length of the larvae was evaluated after three days of exposure to kojic acid (400μg/ml). The effect of kojic acid on pupation and adult emergence was also studied.
Results: On determination of feeding deterrence, the DC50 value for kojic acid was found to be 180.645 ± 6.35μg/ml on comparison to azadirachtin (DC50 = 41.372 ± 2.21). The LD50 & LD90 values of kojic acid were found to be 693.52± 51.31 and 1889.13 ± 279.03μg/ml, respectively. The reduction in larval weight and length were 83.24 and 87.50%, respectively. The percentage pupation and adult emergence were reduced by 69% and 64% for the exposed larvae.
Conclusions: Kojic acid showed moderate feeding deterrence, acute toxicity and sublethal growth effects against S. litura.
Export Options
About this article
Cite this article as:
Busi Siddhardha, Rajkumari Jobina and Hnamte Sairengpuii, Feeding Deterrence, Acute Toxicity and Sublethal Growth Effects of Kojic Acid Isolated from Aspergillus funiculosus, The Natural Products Journal 2014; 4 (1) . https://dx.doi.org/10.2174/2210315504666140515004643
DOI https://dx.doi.org/10.2174/2210315504666140515004643 |
Print ISSN 2210-3155 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-3163 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Evaluation of Two Fast Virtual Stenting Algorithms for Intracranial Aneurysm Flow Diversion
Current Neurovascular Research Neurochemistry Changes Associated with Mutations in Familial Parkinsons Disease
Current Medicinal Chemistry Natural Protective Amyloids
Current Protein & Peptide Science Circulating Biomarkers of Collagen Metabolism and Prognosis of Heart Failure with Reduced or Mid-Range Ejection Fraction
Current Pharmaceutical Design Structural Basis for Therapeutic Intervention of uPA/uPAR System
Current Drug Targets PDE5 Inhibitors in Non-Urological Conditions
Current Pharmaceutical Design Translational Challenge Models in Support of Efficacy Studies: Effect of Cerebral Hypoxia on Cognitive Performances in Rodents
CNS & Neurological Disorders - Drug Targets New Kid on the Block: Does Histamine Get Along with Inflammation in Amyotrophic Lateral Sclerosis?
CNS & Neurological Disorders - Drug Targets Nuezhenide Exerts Anti-Inflammatory Activity through the NF-κB Pathway
Current Molecular Pharmacology Cell Adhesion Molecules in Gene and Cell Therapy Approaches for Nervous System Repair
Current Gene Therapy CYP Inhibition-Mediated Drug-Drug Interactions
Current Enzyme Inhibition Docking Studies of Glutamine Valproic Acid Derivative (S)-5- amino-2-(heptan-4-ylamino)-5-oxopentanoic Acid (Gln-VPA) on HDAC8 with Biological Evaluation in HeLa Cells
Anti-Cancer Agents in Medicinal Chemistry A Study on the Biological Activity of 2-thioxo-imidazolidin-4-ones
Letters in Drug Design & Discovery Mechanisms of Neuropathic Pain
Current Medicinal Chemistry - Central Nervous System Agents Nanotechnology for Alzheimer Disease
Current Alzheimer Research Terpenes and Phenylpropanoids as Acetyl- and Butyrylcholinesterase Inhibitors: A Comparative Study
Current Alzheimer Research Women and Schizophrenia: Sex-Based Pharmacotherapy
Current Psychiatry Reviews Natural AD-Like Neuropathology in Octodon degus: Impaired Burrowing and Neuroinflammation
Current Alzheimer Research Negative Regulation of TCR Signaling in Immunological Tolerance: Taming Good and Evil
Current Immunology Reviews (Discontinued) Anticonvulsant and Neurotoxicity of Some Novel 1-([1,3,4]thiadiazino[6,5- b]indol-3-yl Semicarbazides
Central Nervous System Agents in Medicinal Chemistry